Literature DB >> 22057271

Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles.

Zhongwen Xie1, Dexiang Liu, Shu Liu, Lindsay Calderon, Guogang Zhao, John Turk, Zhenheng Guo.   

Abstract

Mice deficient in regulator of G-protein signaling-2 (RGS2) have severe hypertension, and RGS2 genetic variations occur in hypertensive humans. A potentially important negative feedback loop in blood pressure homeostasis is that angiotensin II (Ang II) increases vascular smooth muscle cell (VSMC) RGS2 expression. We reported that Group VIA phospholipase A(2) (iPLA(2)β) is required for this response (Xie, Z., Gong, M. C., Su, W., Turk, J., and Guo, Z. (2007) J. Biol. Chem. 282, 25278-25289), but the specific molecular causes and consequences of iPLA(2)β activation are not known. Here we demonstrate that both protein kinases C (PKC) and A (PKA) participate in Ang II-induced VSMC RGS2 mRNA up-regulation, and that actions of PKC and PKA precede and follow iPLA(2)β activation, respectively. Moreover, we identified a conserved cAMP-response element (CRE) in the murine RGS2 promoter that is critical for cAMP-response element-binding protein (CREB) binding and RGS2 promoter activation. Forskolin-stimulated RGS2 mRNA up-regulation is inhibited by CREB sequestration or specific disruption of the CREB-RGS2 promoter interaction, and Ang II-induced CREB phosphorylation and nuclear localization are blocked by iPLA(2)β pharmacologic inhibition or genetic ablation. Ang II-induced intracellular cyclic AMP accumulation precedes CREB phosphorylation and is diminished by inhibiting iPLA(2), cyclooxygenase, or lipoxygenase. Moreover, three single nucleotide polymorphisms identified in hypertensive patients are located in the human RGS2 promoter CREB binding site. Point mutations corresponding to these single nucleotide polymorphisms interfere with stimulation of human RGS2 promoter activity by forskolin. Our studies thus delineate a negative feedback loop to attenuate Ang II signaling in VSMC with potential importance in blood pressure homeostasis and the pathogenesis of human essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057271      PMCID: PMC3247950          DOI: 10.1074/jbc.M111.265462

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives.

Authors:  Evan L Riddle; Brinda K Rana; Kenton K Murthy; Fangwen Rao; Eleazar Eskin; Daniel T O'Connor; Paul A Insel
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

2.  Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II.

Authors:  Andrea Semplicini; Livia Lenzini; Michelangelo Sartori; Italia Papparella; Lorenzo A Calò; Elisa Pagnin; Giacomo Strapazzon; Clara Benna; Rodolfo Costa; Angelo Avogaro; Giulio Ceolotto; Achille C Pessina
Journal:  J Hypertens       Date:  2006-06       Impact factor: 4.844

3.  Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population.

Authors:  Jin Yang; Kei Kamide; Yoshihiro Kokubo; Shin Takiuchi; Chihiro Tanaka; Mariko Banno; Yoshikazu Miwa; Masayoshi Yoshii; Takeshi Horio; Akira Okayama; Hitonobu Tomoike; Yuhei Kawano; Toshiyuki Miyata
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

4.  Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.

Authors:  Zhongwen Xie; Wen Su; Zhenheng Guo; Huan Pang; Steven R Post; Ming C Gong
Journal:  Cardiovasc Res       Date:  2005-12-05       Impact factor: 10.787

5.  Involvement of cAMP-response element binding protein-1 in arachidonic acid-induced vascular smooth muscle cell motility.

Authors:  Nagadhara Dronadula; Farhan Rizvi; Eva Blaskova; Quanyi Li; Gadiparthi N Rao
Journal:  J Lipid Res       Date:  2005-12-28       Impact factor: 5.922

6.  Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells.

Authors:  Huan Pang; Zhenheng Guo; Zhongwen Xie; Wen Su; Ming C Gong
Journal:  Am J Physiol Cell Physiol       Date:  2005-11-02       Impact factor: 4.249

7.  Genetic and pharmacologic evidence that calcium-independent phospholipase A2beta regulates virus-induced inducible nitric-oxide synthase expression by macrophages.

Authors:  Jason M Moran; R Mark L Buller; Jane McHowat; John Turk; Mary Wohltmann; Richard W Gross; John A Corbett
Journal:  J Biol Chem       Date:  2005-06-08       Impact factor: 5.157

8.  Interactions among genetic variants from contractile pathway of vascular smooth muscle cell in essential hypertension susceptibility of Chinese Han population.

Authors:  Qi Zhao; Laiyuan Wang; Wei Yang; Shufeng Chen; Jianfeng Huang; Zhongjie Fan; Hongfan Li; Xiangfeng Lu; Dongfeng Gu
Journal:  Pharmacogenet Genomics       Date:  2008-06       Impact factor: 2.089

9.  Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.

Authors:  Zhongwen Xie; Ming C Gong; Wen Su; John Turk; Zhenheng Guo
Journal:  J Biol Chem       Date:  2007-07-05       Impact factor: 5.157

10.  Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice.

Authors:  Hantz C Hercule; Jens Tank; Ralph Plehm; Maren Wellner; Andrey C da Costa Goncalves; Maik Gollasch; André Diedrich; Jens Jordan; Friedrich C Luft; Volkmar Gross
Journal:  Exp Physiol       Date:  2007-07-20       Impact factor: 2.969

View more
  25 in total

Review 1.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

2.  Deletion of BMAL1 in Smooth Muscle Cells Protects Mice From Abdominal Aortic Aneurysms.

Authors:  Jenny Lutshumba; Shu Liu; Yu Zhong; Tianfei Hou; Alan Daugherty; Hong Lu; Zhenheng Guo; Ming C Gong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-08       Impact factor: 8.311

Review 3.  Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.

Authors:  Robert Newton; Mark A Giembycz
Journal:  Br J Pharmacol       Date:  2016-11-09       Impact factor: 8.739

Review 4.  Regulator of G Protein Signaling 2: A Versatile Regulator of Vascular Function.

Authors:  Patrick Osei-Owusu; Kendall J Blumer
Journal:  Prog Mol Biol Transl Sci       Date:  2015-04-16       Impact factor: 3.622

Review 5.  Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins.

Authors:  Mohammed Alqinyah; Shelley B Hooks
Journal:  Cell Signal       Date:  2017-10-16       Impact factor: 4.315

6.  Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation.

Authors:  Zhongwen Xie; Wen Su; Shu Liu; Guogang Zhao; Karyn Esser; Elizabeth A Schroder; Mellani Lefta; Harald M Stauss; Zhenheng Guo; Ming Cui Gong
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

7.  RGS2 is a feedback inhibitor of melatonin production in the pineal gland.

Authors:  Masahiro Matsuo; Steven L Coon; David C Klein
Journal:  FEBS Lett       Date:  2013-03-21       Impact factor: 4.124

8.  Activation of the renin-angiotensin system, specifically in the subfornical organ is sufficient to induce fluid intake.

Authors:  Jeffrey P Coble; Martin D Cassell; Deborah R Davis; Justin L Grobe; Curt D Sigmund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-25       Impact factor: 3.619

Review 9.  Functional role, mechanisms of regulation, and therapeutic potential of regulator of G protein signaling 2 in the heart.

Authors:  Peng Zhang; Ulrike Mende
Journal:  Trends Cardiovasc Med       Date:  2013-08-17       Impact factor: 6.677

10.  CaMKIIδ-dependent inhibition of cAMP-response element-binding protein activity in vascular smooth muscle.

Authors:  Yongfeng Liu; Li-Yan Sun; Diane V Singer; Roman Ginnan; Harold A Singer
Journal:  J Biol Chem       Date:  2013-10-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.